Skip to main content
Clinical Trials/KCT0003052
KCT0003052
Recruiting
未知

A clinical trial to investigate the factors affecting adverse drug reactions and clinical efficacy of clozapine in Korean

Kyung Hee University0 sites100 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Mental and behavioral disorders
Sponsor
Kyung Hee University
Enrollment
100
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Observational Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • ?Patients who can provide their written informed consents according to GCP and related regulations
  • ?Men and women over the age of 19
  • ?Patients who are diagnosed as schizophrenia spectrum disorder according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM\-5\) and expected to use clozapine for more than 57 days(More than 14 days after the last dose of clozapine in patients who previously used clozapine)
  • ?Patients who understand the contents of the clinical research explanations and have given written informed consents

Exclusion Criteria

  • ? Patients who took a drug that the investigator deemed inappropriate before clozapine administration within 2 weeks before screening. (which may be acceptable if the investigator considers to have no effect on pharmacokinetics or safety of the study drug)
  • ? Patients who are planning a pregnancy or who can not use approved methods for contraception during the study period
  • ? Patients who are considered to be inappropriate for study participation by the investigator based on other reasons including clinical laboratory test results

Outcomes

Primary Outcomes

Not specified

Similar Trials